Surgery Notes

Until now there has been no study demonstrating a relationship between the presence of breast implants and cancer. However, the drug agency (FDA) has reported a possible link between breast implants and the development of a type of cancer: anaplastic large cell lymphoma (ALCL).

The FDA has published a review concluding that, from 1997 to present, 60 women worldwide to have developed breast implants ALCL. We should clarify that it is estimated that between 5 and 10 million women breast implants.

ALCL is a rare cancer but very aggressive, affecting three out of 100 million people in the United States. ALCL is a type of non-Hodgkin lymphoma positive for Ki-1 antigen, which can occur in lymph nodes, skin, bones, soft tissues, lungs or liver. In the case of women with implants breast symptoms who have registered are persistent swelling, lumps and pain in the areas near the implant (in the periprosthetic capsule), which occurs between one and twenty-three years after implantation. The information provided by the FDA does not conclude in any way that breast implants cause cancer.

The goal, the agency said the drug is not “alarming”, but as indicated by the chief scientist of the Center for Devices and Radiological Health of the FDA, William Maisel, “better understand the development of this cancer.” In this sense, the health authority plans to make public anticipates that in spring the findings of ongoing studies on silicone implants.

This image provided by the FDA, helps us understand
the news. Lymphoma (in blue) is concentrated between the implant
(Gray) and the capsule around it (purple).
On the website of the FDA are some tips for women. The FDA has established a registry of implants for the collection of data on women who carry breast implants. This registration will result over the years, to conclude whether women who increased their breasts with implants are at increased risk of any disease. Meanwhile, Binita Ashar Dr. wants to reassure women and says: ” If a woman with breast implants have no symptoms, the FDA does not recommend anything more. Women should continue to monitor your implant and continue with their regular assessments. The FDA does not recommend the removal of the implants . Women who see changes in how the area around the implant or feel pain or swelling around the implant, you should consult a doctor for evaluation. Women considering the breast implants should be aware of small but increased risk of ALCL and discuss with a doctor.”

Possibly Related Articles:

• Risks of Breast Implants and Side Effects
  While the breast implants are becoming more risky when performed and postoperative effects less bothersome and complex, there are, for this surgery, e...
• Social Security will cover replacement of breast implants PIP
  The Ministry of Health, Social Services and Equal, has granted assistance to women who have been implanted with breast implants Implant Prothèse Poly ...
• Myths surgery breast enlargement
  Breast enlargement surgery bilateral (sometimes called breast enlargement) is the procedure most commonly performed cosmetic surgery in the United Kin...
• Choosing the Breast Implant Size
  The rating of the breast implant is a very important step in breast augmentation because the size of the implant that you choose to achieve the desire...
• Implants and Breast Cancer
  One of the most widespread myths that exist about mammoplasty augmentation is that the implants are placed in the breast could cause breast cancer. Th...